FDA Inspection 1027581 — Robert Wood Johnson University Hospital
The FDA completed an inspection of Robert Wood Johnson University Hospital on September 26, 2017 in New Brunswick, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 26, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- New Brunswick, NJ (United States)